|
|
   Adalimumab
|
|
|
| appearance as argument number 1 |
|
|
| (documentation Adalimumab EnglishLanguage "Adalimumab, is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα). It is sold under the brand name Humira, among others. It is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, CrohnsDisease, UlcerativeColitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic Arthritis. Use is generally only recommended in people who have not responded to other treatments. It is administered by injection under the skin. Common side effects include upper respiratory tract infections, pain at the site of injection, rash, and headache. Other side effects may include serious infections, cancer, anaphylaxis, reactivation of hepatitis B, multiple sclerosis, heart failure, liver failure, and aplastic anemia. Use during pregnancy is not recommended, but some sources show use during breastfeeding may be safe.[from Wikipedia]") | Medicine.kif 3607-3621 | |
| (sideEffect Adalimumab Headache) | Medicine.kif 3626-3626 | sideEffect Adalimumab and Headache |
| (sideEffect Adalimumab SkinRash) | Medicine.kif 3625-3625 | sideEffect Adalimumab and SkinRash |
| (subclass Adalimumab Medicine) | Medicine.kif 3605-3605 | Adalimumab est une sous-classe de Medicine |
| appearance as argument number 2 |
|
|
| (subclass Humira Adalimumab) | Medicine.kif 3646-3646 | Humira est une sous-classe de Adalimumab |
| (termFormat EnglishLanguage Adalimumab "adalimumab") | Medicine.kif 3622-3622 |
| antecedent |
|
|
| (=> (and (instance ?I Injecting) (instance ?A Adalimumab) (objectTransferred ?I ?A) (located ?I ?BP) (instance ?BP BodyPart) (destination ?I ?H)) (modalAttribute (exists (?T) (and (holdsDuring ?T (attribute ?H (PainFn ?BP))) (during ?T (FutureFn (WhenFn ?I))))) Likely)) |
Medicine.kif 3628-3644 |
|
|
|
|